US Equity

And you should be, too.
Genocea Biosciences and Eiger Biopharmaceuticals are high risk/high reward plays.
This reaction today is worrisome, but there isn't any major shift in market character yet.
$180 is our next price target.
You may not like their food, but these 4 stocks could deserve a bearish or bullish bite.
AMZN just keeps climbing.
Benchmark Electronics, FreightCar America, Kulicke & Soffa and AVX Corporation are on my radar as potential targets.
This stock performs well, and volume levels are up.
And the crowd has become a bit more nervous, according to the Total and Equity Put/Call Ratios.
A long call shooter on WEAT, expiring in October.


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.